当前位置: 首页 > 期刊 > 《中国医学创新》 > 2018年第32期
编号:13267652
Lp(a)的颗粒浓度在评估心血管风险中的应用价值(4)
http://www.100md.com 2018年11月15日 《中国医学创新》 2018年第32期
     [13] Hashemzadeh A A,Nasoohi N,Raygan F,et al.Flaxseed Oil Supplementation Improve Gene Expression Levels of PPAR-γ,LP(a),IL-1 and TNF-α in Type 2 Diabetic Patients with Coronary Heart Disease[J].Lipids,2017,52(Suppl 1):1-9.

    [14] Jacobson T A.Lipoprotein(a),cardiovascular disease,and contemporary management[J].Mayo Clin Proc,2013,88(11):1294-1311.

    [15] Huang M,Gong Y,Grondolsky J,et al.Lp(a)/apo(a) modulate MMP-9 activation and neutrophil cytokines in vivo in inflammation to regulate leukocyte recruitment[J].American Journal of Pathology,2014,184(5):1503-1517.

    [16]张凯,邓智敏,曾召林,等.ox-Lp(a)通过上调miR-125a-5p靶向抑制10,11-转位酶2增加单层血管内皮细胞通透性[J].中国动脉硬化杂志,2017,25(11):1107-1113.

    [17] Scipione C A,Sayegh S E,Romagnuolo R,et al.Mechanistic insights into Lp(a)-induced IL-8 expression:a role for oxidized phospholipid modification of apo(a)[J].J Lipid Res,2015,56(12):2273.

    [18]費志宏,周静,孙文阁,等.52例蒙古族肾病综合征患者脂蛋白(a)水平的临床分析[J].现代预防医学,2013,40(17):3322-3324.

    [19] De A L P,Cardososalda?a G,Zamoragonzález J,et al.

    Functional approach to investigate Lp(a) in ischaemic heart and cerebral diseases[J].Eur J Clin Invest,2015,33(2):99-105.

    [20] Boffa M B,Koschinsky M L.Screening for and management of elevated Lp(a)[J].Curr Cardiol Rep,2013,15(11):1-8., 百拇医药(温小云 方先松 沈志明)
上一页1 2 3 4